• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道来源的血清脂多糖与心房颤动患者发生主要不良心血管事件的风险增加有关:坚持地中海饮食的影响。

Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.

作者信息

Pastori Daniele, Carnevale Roberto, Nocella Cristina, Novo Marta, Santulli Maria, Cammisotto Vittoria, Menichelli Danilo, Pignatelli Pasquale, Violi Francesco

机构信息

I Clinica Medica, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy.

Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Italy.

出版信息

J Am Heart Assoc. 2017 Jun 5;6(6):e005784. doi: 10.1161/JAHA.117.005784.

DOI:10.1161/JAHA.117.005784
PMID:28584074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5669181/
Abstract

BACKGROUND

Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the predictive role of gut-derived lipopolysaccharide (LPS) is unknown. We analyzed (1) the association between LPS and major adverse cardiovascular events (MACE) in atrial fibrillation (AF) and (2) its relationship with adherence to a Mediterranean diet (Med-diet).

METHODS AND RESULTS

This was a prospective single-center study including 912 AF patients treated with vitamin K antagonists (3716 patient-years). The primary end point was a composite of MACE. Baseline serum LPS, adherence to Med-diet (n=704), and urinary excretion of 11-dehydro-thromboxane B (TxB, n=852) were investigated. Mean age was 73.5 years; 42.9% were women. A total of 187 MACE (5.0% per year) occurred: 54, 59, and 74 in the first, second, and third tertile of LPS, respectively (log-rank test =0.004). Log-LPS (hazard ratio 1.194, =0.009), age (hazard ratio 1.083, <0.001), and previous cerebrovascular (hazard ratio 1.634, =0.004) and cardiac events (hazard ratio 1.822, <0.001) were predictors of MACE. In the whole cohort, AF (versus sinus rhythm) (β 0.087, =0.014) and low-density lipoprotein cholesterol (β 0.069, =0.049) were associated with circulating LPS. Furthermore, Med-diet score (β -0.137, <0.001) was predictive of log-LPS, with fruits (β -0.083, =0.030) and legumes (β -0.120, =0.002) negatively associated with log-LPS levels. Log-LPS and log-TxB were highly correlated (r=0.598, <0.001). Log-LPS (β 0.574, <0.001) and Med-diet score (β -0.218, <0.001) were significantly associated with baseline urinary excretion of TxB.

CONCLUSIONS

In this cohort of AF patients, LPS levels were predictive of MACE and negatively affected by high adherence to Med-diet. LPS may contribute to MACE incidence in AF by increasing platelet activation.

摘要

背景

肠道微生物群正成为动脉粥样硬化血栓形成的一个新的危险因素,但肠道来源的脂多糖(LPS)的预测作用尚不清楚。我们分析了(1)LPS与房颤(AF)患者主要不良心血管事件(MACE)之间的关联,以及(2)其与坚持地中海饮食(Med-diet)的关系。

方法和结果

这是一项前瞻性单中心研究,纳入了912例接受维生素K拮抗剂治疗的AF患者(3716患者-年)。主要终点是MACE的复合终点。研究了基线血清LPS、对Med-diet的依从性(n = 704)以及11-脱氢血栓素B(TxB,n = 852)的尿排泄情况。平均年龄为73.5岁;42.9%为女性。共发生187例MACE(每年5.0%):LPS三分位数的第一、第二和第三组分别为54例、59例和74例(对数秩检验=0.004)。Log-LPS(风险比1.194,P = 0.009)、年龄(风险比1.083,P < 0.001)以及既往脑血管事件(风险比1.634,P = 0.004)和心脏事件(风险比1.822,P < 0.001)是MACE的预测因素。在整个队列中,AF(与窦性心律相比)(β 0.087,P = 0.014)和低密度脂蛋白胆固醇(β 0.069,P = 0.049)与循环LPS相关。此外,Med-diet评分(β -0.137,P < 0.001)可预测Log-LPS,水果(β -0.083,P = 0.030)和豆类(β -0.120,P = 0.002)与Log-LPS水平呈负相关。Log-LPS和Log-TxB高度相关(r = 0.598,P < 0.001)。Log-LPS(β 0.574,P < 0.001)和Med-diet评分(β -0.218,P < 0.001)与TxB的基线尿排泄显著相关。

结论

在这个AF患者队列中,LPS水平可预测MACE,并受到对Med-diet高依从性的负面影响。LPS可能通过增加血小板活化促进AF患者MACE的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec5/5669181/83b92305ec6b/JAH3-6-e005784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec5/5669181/83b92305ec6b/JAH3-6-e005784-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aec5/5669181/83b92305ec6b/JAH3-6-e005784-g001.jpg

相似文献

1
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.肠道来源的血清脂多糖与心房颤动患者发生主要不良心血管事件的风险增加有关:坚持地中海饮食的影响。
J Am Heart Assoc. 2017 Jun 5;6(6):e005784. doi: 10.1161/JAHA.117.005784.
2
Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.地中海饮食可降低房颤患者血栓素 A2 的生成。
Clin Nutr. 2015 Oct;34(5):899-903. doi: 10.1016/j.clnu.2014.09.011. Epub 2014 Sep 28.
3
Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.载脂蛋白 C-III 与尿血栓素排泄对心房颤动患者心血管事件的关系。
J Am Coll Cardiol. 2017 Sep 19;70(12):1455-1462. doi: 10.1016/j.jacc.2017.07.743.
4
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists.地中海饮食与服用维生素 K 拮抗剂的房颤患者治疗范围内时间的关系。
Europace. 2015 Aug;17(8):1223-8. doi: 10.1093/europace/euv127. Epub 2015 May 19.
5
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.维生素K拮抗剂抗凝不足与心房颤动患者的主要不良心血管事件相关。
Int J Cardiol. 2015 Dec 15;201:513-6. doi: 10.1016/j.ijcard.2015.08.054. Epub 2015 Aug 5.
6
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort.血清内毒素血症与前蛋白转化酶枯草溶菌素 9(PCSK9)在心房颤动患者中的相互作用:ATHERO-AF 队列的事后分析。
Atherosclerosis. 2019 Oct;289:195-200. doi: 10.1016/j.atherosclerosis.2019.07.002. Epub 2019 Jul 4.
7
Serum Lipopolysaccharide Is Associated with the Recurrence of Atrial Fibrillation after Radiofrequency Ablation by Increasing Systemic Inflammation and Atrial Fibrosis.血清脂多糖通过增加全身炎症和心房纤维化与射频消融术后心房颤动的复发相关。
Oxid Med Cell Longev. 2022 Oct 15;2022:2405972. doi: 10.1155/2022/2405972. eCollection 2022.
8
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.尿11-脱氢血栓素B2与心房颤动患者的心血管事件及死亡率相关。
Am Heart J. 2015 Sep;170(3):490-7.e1. doi: 10.1016/j.ahj.2015.05.011. Epub 2015 May 22.
9
High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease.高依从地中海饮食与非酒精性脂肪性肝病患者血小板活化和肝胶原沉积降低相关。
Nutrients. 2022 Mar 12;14(6):1209. doi: 10.3390/nu14061209.
10
Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients?房颤患者坚持地中海饮食、抗氧化状态与血管疾病之间是否存在相互作用?
Antioxid Redox Signal. 2016 Nov 10;25(14):751-755. doi: 10.1089/ars.2016.6839. Epub 2016 Sep 30.

引用本文的文献

1
Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy.微生物代谢产物与心血管功能障碍:诊断与治疗的新时代。
Cells. 2025 Aug 11;14(16):1237. doi: 10.3390/cells14161237.
2
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.肠道微生物群及其代谢产物的作用:糖尿病及其并发症的新预测指标。
Eur J Med Res. 2025 Jul 9;30(1):601. doi: 10.1186/s40001-025-02824-9.
3
Impact of gut microbiome on atrial fibrillation: Mechanistic insights and future directions in individualized medicine.

本文引用的文献

1
Gut microbiota dysbiosis contributes to the development of hypertension.肠道微生物失调与高血压的发生发展有关。
Microbiome. 2017 Feb 1;5(1):14. doi: 10.1186/s40168-016-0222-x.
2
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.急性冠状动脉综合征中肠道微生物群依赖性三甲胺 N-氧化物:超越传统危险因素的心血管事件发生的预后标志物。
Eur Heart J. 2017 Mar 14;38(11):814-824. doi: 10.1093/eurheartj/ehw582.
3
Role of gut microbiota in atherosclerosis.
肠道微生物群对心房颤动的影响:个性化医学的机制见解与未来方向
World J Cardiol. 2025 Jun 26;17(6):107386. doi: 10.4330/wjc.v17.i6.107386.
4
Potential role of gut microbiota in cardiac arrhythmias.肠道微生物群在心律失常中的潜在作用。
Am Heart J Plus. 2025 May 28;55:100557. doi: 10.1016/j.ahjo.2025.100557. eCollection 2025 Jul.
5
A promising approach to diabetic osteoporosis: oxymatrine's effects on gut microbiota and osteoblasts.糖尿病性骨质疏松症的一种有前景的治疗方法:氧化苦参碱对肠道微生物群和成骨细胞的影响。
Nutr Diabetes. 2025 May 7;15(1):19. doi: 10.1038/s41387-025-00374-x.
6
Gut Microbiota in Heart Failure-The Role of Inflammation.心力衰竭中的肠道微生物群——炎症的作用。
Biomedicines. 2025 Apr 9;13(4):911. doi: 10.3390/biomedicines13040911.
7
Dietary intake in healthy older individuals is associated with lipopolysaccharide binding protein a biomarker of gut function: an exploratory cross-sectional study.健康老年人的饮食摄入与脂多糖结合蛋白(一种肠道功能生物标志物)相关:一项探索性横断面研究。
Front Aging. 2025 Mar 31;6:1572867. doi: 10.3389/fragi.2025.1572867. eCollection 2025.
8
The gut-heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development.肠道-心脏轴:肠道微生物群、生态失调与心血管疾病发展综述
Ann Med Surg (Lond). 2025 Jan 9;87(1):177-191. doi: 10.1097/MS9.0000000000002789. eCollection 2025 Jan.
9
Cardiometabolic disease risk in gorillas is associated with altered gut microbial metabolism.大猩猩的心脏代谢疾病风险与肠道微生物代谢改变有关。
NPJ Biofilms Microbiomes. 2025 Feb 21;11(1):33. doi: 10.1038/s41522-025-00664-3.
10
Gut microbiota-related modulation of immune mechanisms in post-infarction remodelling and heart failure.肠道微生物群对心肌梗死后重塑和心力衰竭中免疫机制的相关调节作用
ESC Heart Fail. 2025 Apr;12(2):942-954. doi: 10.1002/ehf2.14991. Epub 2024 Oct 9.
肠道微生物群在动脉粥样硬化中的作用。
Nat Rev Cardiol. 2017 Feb;14(2):79-87. doi: 10.1038/nrcardio.2016.183. Epub 2016 Dec 1.
4
The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: Long-term results from a multicenter study.维生素K拮抗剂在既往有溃疡出血的房颤患者中的安全性和有效性:一项多中心研究的长期结果
Medicine (Baltimore). 2016 Nov;95(47):e5467. doi: 10.1097/MD.0000000000005467.
5
Postprandial serum endotoxin in healthy humans is modulated by dietary fat in a randomized, controlled, cross-over study.在一项随机、对照、交叉研究中,健康人体内的餐后血清内毒素受膳食脂肪调节。
Lipids Health Dis. 2016 Nov 5;15(1):186. doi: 10.1186/s12944-016-0357-6.
6
Increased intestinal permeability as a risk factor for type 2 diabetes.肠道通透性增加作为2型糖尿病的一个风险因素。
Diabetes Metab. 2017 Apr;43(2):163-166. doi: 10.1016/j.diabet.2016.09.004. Epub 2016 Oct 10.
7
Low-grade endotoxemia and platelet activation in cirrhosis.肝硬化患者的低水平内毒素血症和血小板活化。
Hepatology. 2017 Feb;65(2):571-581. doi: 10.1002/hep.28853. Epub 2016 Nov 5.
8
Microbiome, trimethylamine N-oxide, and cardiometabolic disease.微生物群、氧化三甲胺与心脏代谢疾病
Transl Res. 2017 Jan;179:108-115. doi: 10.1016/j.trsl.2016.07.007. Epub 2016 Jul 18.
9
Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.将肠道微生物群与炎症与肥胖和胰岛素抵抗联系起来。
Physiology (Bethesda). 2016 Jul;31(4):283-93. doi: 10.1152/physiol.00041.2015.
10
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.血清氧化三甲胺(TMAO)水平与人类早期动脉粥样硬化的关系。
Sci Rep. 2016 May 27;6:26745. doi: 10.1038/srep26745.